|
N-Gene Research Laboratories Biopharmaceutical Diabetic Research Laboratory
|
|
|
 |
 |
| |
|
|
| |
BGP-15 Product
Profile
N-Gene's development program is geared towards collecting
data with regard to the following product profile for
BGP-15:
- First label in type 2 diabetes, mono-therapy and
combination treatment with other anti-diabetics for glycemic
control
- Second label as adjunct to anti-schizophrenics,
attenuation of insulin resistance and weight gain
- Potential additional indications due to cardio-vascular
benefits (e.g. atherosclerosis) or metabolic control (e.g.
pre-diabetes, metabolic syndrome) |
|
| |
|
|
|
|
|
|
© N-Gene Research Laboratories
All rights reserved. Reproduction prohibited. |
|
